Skip to main content
. 2012 Feb 13;47(10):1312–1317. doi: 10.1038/bmt.2012.1

Table 4.

Hazard ratios for outcomes in patients with multiple myeloma receiving transplants from allogeneic donors, comparing patients receiving non-myeloablative conditioning to those receiving myeloablative conditioning

HR (95% CI) P
Overall mortality 0.40 (0.3–0.6) <0.0001
PFS 0.55 (0.4–0.8) 0.0002
TRM 0.22 (0.1–0.4) <0.0001
Relapse/prog 1.20 (0.8–1.9) 0.43
Acute GVHD 0.41 (0.3–0.6) <0.0001
Chronic GVHD 0.86 (0.5–1.4) 0.51